SEARCH

SEARCH BY CITATION

Keywords:

  • Contraceptive vaccine;
  • immunocontraception;
  • implantation;
  • pregnancy-specific factors

Abstract

  1. Top of page
  2. Abstract
  3. Introduction
  4. Discussion
  5. Acknowledgements
  6. References

Citation Lemons AR, Naz RK. Contraceptive vaccines targeting factors involved in establishment of pregnancy. Am J Reprod Immunol 2011; 66: 13–25

Current methods of contraception lack specificity and are accompanied with serious side effects. A more specific method of contraception is needed. Contraceptive vaccines can provide most, if not all, the desired characteristics of an ideal contraceptive. This article reviews several factors involved in the establishment of pregnancy, focusing on those that are essential for successful implantation. Factors that are both essential and pregnancy-specific can provide potential targets for contraception. Using database search, 76 factors (cytokines/chemokines/growth factors/others) were identified that are involved in various steps of the establishment of pregnancy. Among these factors, three, namely chorionic gonadotropin (CG), leukemia inhibitory factor (LIF), and pre-implantation factor (PIF), are found to be unique and exciting molecules. Human CG is a well-known pregnancy-specific protein that has undergone phase I and phase II clinical trials, in women, as a contraceptive vaccine with encouraging results. LIF and PIF are pregnancy-specific and essential for successful implantation. These molecules are intriguing and may provide viable targets for immunocontraception. A multiepitope vaccine combining factors/antigens involved in various steps of the fertilization cascade and pregnancy establishment may provide a highly immunogenic and efficacious modality for contraception in humans.


Introduction

  1. Top of page
  2. Abstract
  3. Introduction
  4. Discussion
  5. Acknowledgements
  6. References

With the continually increasing world population, there is an urgent need for an alternative form of contraception. Currently available methods, including most used modalities, namely steroid contraceptives and intrauterine devices (IUD) have several serious side effects. A more targeted, less invasive approach to contraception is desired. Contraceptive vaccines (CV) would provide an ideal alternative. CV would be easy to administer, less expensive, readily available, and more importantly, would be specific. By targeting factors that are essential for establishment of pregnancy, a CV would block the action of a factor(s) and prevent the onset of pregnancy. One of the essential factors that has been extensively studied is the chorionic gonadotropin (CG). Human chorionic gonadotropin (hCG) is a major systemic regulator of embryo development, implantation and is secreted by the implanting trophoblast,1 making it an ideal pregnancy-specific target for CV development. Several forms of hCG vaccines have undergone clinical trials in women, both phase I and phase II, displaying positive contraceptive effects.2,3 While the outlook of the hCG vaccine looks promising, research on additional potential targets continue with an ultimate goal of finding a vaccine that is more immunogenic and efficacious. This article will review the additional factors that are involved in the development and implantation of the embryo, with a focus on those that have been shown to be essential for normal embryonic development and/or implantation and pregnancy-specific. The long-term goal is to target these molecules for the development of highly specific, non-steroidal, and efficacious vaccine for birth control.

Discussion

  1. Top of page
  2. Abstract
  3. Introduction
  4. Discussion
  5. Acknowledgements
  6. References

Factors Involved in Various Stages of Establishment of Pregnancy

The PubMed database (http://www.pubmed.gov) was searched using the following keywords: secreted/pregnancy/fertilization/implantation/embryo development/pregnancy-specific/molecules. Further focus was placed on those articles that were relevant to murine or human implantation and pregnancy. The search identified 76 cytokines, chemokines, growth factors, integrins, and miscellaneous factors involved in the establishment of pregnancy. Their molecular and functional parameters are summarized in Tables I–III. These 76 factors are grouped into five categories depending upon which stage of pregnancy establishment they are primarily involved in and described below (Fig. 1).

Table I.   Cytokines Involved in the Establishment of Pregnancy
ProteinSize (kDa)Human geneRoleSpecies
Interleukins
 IL-1α18IL1AInduces changes for adhesion and invasion44,45Human/mouse
 IL-1β17.5IL1BInduces changes for adhesion and stimulates IL-8 production43,44,46Human/mouse
 IL-1 receptor antagonist (IL-1Ra)17lL1RNPrevents adhesion47Mouse
 IL-626IL6Stimulates leptin secretion and metalloproteinase activity74Human/mouse
 IL-1018IL10Decreases cytotoxic activation of uNK cells107Human/mouse
 IL-1123IL11Receptor signaling required for decidua development71–73Human/mouse
 IL-1275IL12A/IL12BImmunomodulatory104Human
 IL-1518IL15Regulates IL-8 expression and uNK cells85Human
 IL-1818IL18Increases perforin expression and cytolytic potentials of uNK cells105Human
 IL-2321IL23A/IL12BImmunomodulatory, regulates IL-8 expression99,108Human/mouse
 IL-2727EBI3/IL30Immunomodulatory108Mouse
 Leukemia inhibitory factor (LIF)26LIFRegulates expression of genes important in implantation19,20Human/mouse
CSFs
 Granulocyte colony-stimulating factor (G-CSF)∼19CSF3Recruits macrophages to the uterus to prepare it for implantation90Mouse
 Granulocyte macrophage colony-stimulating factor (GM-CSF)14.4CSF2Enhances proliferation and viability of blastomeres14,15Mouse
 Macrophage colony-stimulating factor (M-CSF)∼36CSF1Recruits macrophages to the uterus to prepare it for implantation89,90Mouse
TGFβ superfamily
 Activin A24–28INHBAPromotes decidualization; prevents activation of T cells68–70Mouse
 Macrophage inhibitory cytokine (MIC-1)25GDF15Regulates trophoblast migration/invasion and decidualization39,85Human
 Transforming growth factor β1 (TGFβ1)25TGFB1Regulate embryo development12,13Human/mouse
 Transforming growth factor β2 (TGFβ2)25TGFB2Regulate embryo development12Human
 Transforming growth factor β3 (TGFβ3)25TGFB3Promotes a regulatory T cell response111Mouse
TNF Family
 Tumor necrosis factor-α (TNF-α)25TNFImmunomodulatory, has deleterious effects at high levels4–6Human/mouse
 Tumor necrosis factor-like weak inducer of apoptosis (TWEAK)17TWEAKControls cytotoxicity, possibly through regulation of IL-15 and IL-18108,113Human/mouse
Hormones
 Growth hormone (GH)22GH1/GH2Effects quality of embryo and fertilization rate17Human
 Prolactin (PRL)24PRLPromotes decidualization76Human/mouse
Table II.   Chemokines and Growth Factors Involved in the Establishment of Pregnancy
ProteinSizeHuman GeneRoleSpecies
Chemokines
 CCL-2 (MCP-1)∼11CCL2Recruits monocytes, macrophages and T cells in the endometrium89,92,93,95Human/mouse
 CCL-3 (MIP1α)7.9CCL3Recruits macrophages94Human/mouse
 CCL-4 (MIP-1β)7.62CCL4Recruits macrophages and NK cells; promotes trophoblast migration34,85Human
 CCL5 (RANTES)8CCL5Recruits macrophages; high levels negatively affect fertilization89,92,94Human/mouse
 CCL-7 (MCP-3)8.5CCL7Recruits macrophages and NK cells; implantation requires a downregulation85,96Mouse
 CXCL1 (GRO1; KC)∼11CXCL1Upregulates the inflammatory response94,100Human/mouse
 IL-8 (CXCL8)8.5IL8Regulates expression of inflammatory response genes100,112Human
 CX3CL1 (fractalkine)90CX3CL1Recruits macrophages and NK cells; promotes trophoblast migration; regulates gene expression for adhesion34,48,98Human
EGF family
 Amphiregulin (AREG)9.5–16.5AREGRegulated by leukemia inhibitory factor (LIF), important in implantation18,19Mouse
 Epidermal growth factor (EGF)∼6EGFStimulates trophoblast migration/invasion35,36Human/mouse
 Heparin binding EGF-like growth factor (HB-EGF)22HB-EGFRegulated by LIF; promotes development of blastocyst, motility, attachment and invasion18,24Human/mouse
 Transforming growth factor α (TGFα)17TGFAIncreases the rate of blastocoel expansion28Mouse
Growth factors
 Acrogranin/progranulin68GRNPromotes blastocyst hatching, adhesion and outgrowth29,30Mouse
 Basic fibroblast growth factor (FGF2, bFGF)18–22FGF2Prepares blastocyst for migration25Mouse
 Connective tissue growth factor (CTGF)∼38CTGFRegulates uterine function87,88Human/mouse
 Hepatocyte growth factor (HGF)78HGFRegulates cytotrophoblast differentiation and depth of invasion26Human
 Platelet-derived growth factor (PDGF-A)16PDGFAPromotes trophoblast outgrowth27Mouse
 Prokineticin 1 (PROK1)9.7EGVEGFPromotes expression of implantation-related genes (i.e. LIF)40,41Human
 Vascular endothelial growth factor (VEGF-A)45VEGFAMaintains corpus lutuem67Human
Table III.   Integrins and Other Factors Involved in the Establishment of Pregnancy
ProteinSize (kDa)Human geneRoleSpecies
Integrins
 α4β1 integrin∼280ITGA4/ITGB1Important in implantation and decidualization55Human
 α5β1 integrin∼265ITGA5/ITGB1Essential for the migration of extravillous trophoblasts (IFG-I-induced)37Human
 α9β1 integrin∼230ITGA9/ITGB1Important in implantation26Human
 αvβ3 integrin∼230ITGAV/ITGB3Involved in extravillous trophoblast migration (IGF-I-induced), important in implantation and decidualization18,38,55Human
Other factors
 Adrenomedullin6ADMInvolved in invasion and pinopode formation62–64Human/mouse
 α-fetoprotein70AFPInhibits the immune response118Mouse
 Cochlin (COCH)∼60COCHRegulated by leukemia inhibitory factor (LIF); marker for uterine receptivity?21Mouse
 Corticotropin-releasing hormone (CRH)∼5CRHPromotes implantation by regulating FasL expression114,115Human/mouse
 Cyclooxygenase-2 (COX-2)72PTGS2Synthesizes prostaglandins; required for fertilization, implantation and decidualization79Mouse
 Cytosolic phospholipase A2α (cPLA2α)85cPLA2αProvides arachidonic acid for synthesis of PGs by COX2; deficiency results in abnormal spacing and delayed implantation60Mouse
 Dickkopf-1 (DKK-1)∼25DKK1Required for blastocyst outgrowth and adhesion33Mouse
 Glycodelin28PAEPInvolved in sperm-oocyte binding and prevention of the inflammatory response109,110,124Human
 Heparan sulfate proteoglycans (HSPG)>500n/aExpressed on the trophectoderm of blastocyst during the attachment phase of implantation54Mouse
 Human chorionic gonadotropin (hCG)37.6CGBResponsible for progesterone production and LIF expression; maintains the corpus luteum; also involved in angiogenesis, attachment and immune tolerance1,77,116Human
 Homebox A10 (HOXA-10)∼40HOXA10Required for decidualization and successful implantation82–84Human/mouse
 Homebox A11 (HOXA-11)∼35HOXA11Required for uterine stromal and glandular cell differentiation81Mouse
 Immunoresponsive gene 1 homolog (IRG1)∼52IRG1Regulated by progesterone and LIF; important for implantation19,42Mouse
 Insulin5.8INSIncreases cell proliferation of early stage embryos7,8Mouse
 Insulin-like growth factor I (IGF-I)7.65IGF1Increases number of cells in inner cell mass31Mouse
 Insulin-like growth factor II (IGF-II)7.5IGF2Involved in oocyte maturation and development of the embryo to blastocyst stage9,16Human/mouse
 Insulin-like growth factor binding protein 1 (IGFBP-1)∼25IGFBP1Limits trophoblast growth and inhibits IGF-I activity26,66Human
 Insulin-like growth factor binding protein 2 (IGFBP-3)∼40IGFBP3Upregulated by LIF; involved in oocyte maturation and embryo development9,19Human/mouse
 Interferon-induced 17 kDa protein (ISG15)17ISG15Induced in the endometrium in response to the implanting conceptus; immunomodulatory?117Human/mouse
 Leptin16LEPInvolved in blastocyst development; mediates the invasiveness of the cytotrophoblast32,45,65Human/mouse
 Lysophosphatidic acid receptor 3 (LPA3)40LPAR3Regulates uterine receptivity58,59Mouse
 l-selectin43SELLPlays an early role in the homing of leukocytes the uterus, regulating uterine receptivity102,103Human/mouse
 Mucin 1 (MUC-1)>300MUC1Involved in embyro attachment1,53Mouse/human
 Oviduct-specific glycoprotein (OVGP1; MUC-9)120OVGP1Enhances binding of sperm to the zona pellucida123Human
 Platelet activating factor (PAF)∼524n/aStimulates early embryo development10,11Human/mouse
 Pre-implantation factor (PIF)0.6–1.8n/aRegulates immunity, promotes adhesion and invasion, and regulates apoptotic processes56,57Human
 Prostaglandin E2 (PGE2)352n/aInvolved in the inflammatory response in the endometrium required for implantation1Human
 Secreted phosphoprotein 1 (SPP1)44SPP1Allows for attachment to the luminal epithelium; induces focal adhesions49,50Mouse
 Trophinin69TROInvolved in activation of the trophectoderm for adhesion51Human/mouse
image

Figure 1.  Schematic of the factors involved in the establishment of pregnancy. Factors that are essential and pregnancy-specific are represented in bold. These factors may provide interesting targets for contraception.

Download figure to PowerPoint

Factors involved in early embryonic development

After fertilization, the resultant zygote undergoes a series of divisions and modifications before progressing to the blastocyst stage. Several factors promote growth and proliferation of these early embryos. Tumor necrosis factor-α (TNF-α) has been shown to bind early mouse embryos and may promote embryonic development4; however, it has deleterious effects at high levels.5,6 Insulin has been shown to stimulate DNA, RNA, protein synthesis,7 and increase the rate at which these cells proliferate during the early diploid and tetraploid stages.8 Higher levels of insulin-like growth factor (IGF) binding protein 3 (IGFBP-3) have been correlated with the increased embryonic development.9 The embryo secretes platelet activating factor (PAF) that promotes embryo development.10 Blocking the action of PAF with an antagonist prevents implantation.11 Transforming growth factor (TGF)-β1 plays an important role in the development of the blastocyst.12 TGF-β1 null mice produce embryos that are arrested at the morula stage, not developing to a blastocyst.13 Granulocyte macrophage colony-stimulating factor (GM-CDF) enhances the viability and proliferation of blastomeres in early embryos.14,15 Insulin-like growth factor (IGF)-II also promotes the progression to the blastocyst stage. IGF-II antisense oligodeoxynucleotides (ODN) decrease the rate that embryos enter into the blastocyst stage.16 Another factor affecting the growth and development of early embryos is growth hormone (GH). Patients with in vitro fertilization (IVF) failures have been shown to have GH deficiency. Supplementation with GH improves embryo quality and fertilization rates in these patients.17

Factors affecting development of blastocyst

Once the blastocyst has formed, it must undergo changes that allow for implantation. A few key systemic factors regulate this process. Leukemia inhibitory factor (LIF) is an essential factor whose expression is under the control of progesterone. LIF controls the expression of several implantation-related genes, such as heparin-binding EGF-like growth factor (HB-EGF), amphiregulin, epiregulin, insulin-like growth factor binding protein 3 (IGFBP-3), immunoresponsive gene 1 homolog (IRG-1), and cochlin.18–21 Gene knockout and LIF antagonist studies in mice have shown that deleting the LIF/LIF receptor gene or impeding the interaction of LIF with the receptor results in implantation failure.22,23 HB-EGF promotes the development of blastocysts through the hatching stage as well as the motility and attachment of the blastocyst.24

Several growth factors influence the growth and development of blastocyst. These include TGF-α, basic fibroblast growth factor (FGF-2),25 hepatocyte growth factor (HGF),26 platelet-derived growth factor (PDGFA),27 and acrogranin. TGF-α has been demonstrated to stimulate DNA and protein synthesis in blastocysts as well as increase the rate of blastocoel expansion. Administration of TGF-α antisense ODN significantly reduces the rate of blastocoel expansion.28 Rate of blastocoel expansion is shown to increase in the presence of acrogranin. Not only does it affect expansion, it also promotes blastocyst hatching and outgrowth. Anti-acrogranin antibodies reduce these effects in vitro and also prevent the 8-cell embryos to develop to blastocysts.29,30 The inner cell mass (ICM) continually increases in cell number as the blastocyst develops. IGF-I, IGF-II, and leptin have all been reported to increase the number of ICM in cultured blastocysts.16,31,32 In order for the blastocyst to adhere to the uterus, it must first become activated. The outgrowth and adhesion of blastocysts are inhibited by the addition of Dickkopf-1 (DKK-1) antisense ODN, suggesting an important role for DKK-1 in blastocyst activation.33

Factors impacting implantation

Migration of the blastocyst to the implantation site is controlled by many factors. Several chemokines, including CCL-4 and CX3CL-1, promote blastocyst migration.34 Extravillous trophoblast (EVT) migration is also induced by a handful of growth factors. Epidermal growth factor (EGF) can stimulate trophoblast migration35 using the PI3K/AKT and MAP kinase signaling pathways.36 Along with EGF, IGF-I can also induce EVT migration. The α5β1 and αvβ3 integrins have been shown to play essential roles in this pathway.37,38 FGF-2 may also play a role in preparing the blastocyst for migration.25 Several factors, such as macrophage inhibitory cytokine 1 (MIC-1),39 can act to regulate the migration.

Once at the site of implantation, the blastocyst attaches to the uterine epithelium. Prokineticin 1 (PROK-1) promotes the gene expression of many implantation-related genes, such as cyclooxygenase 2 (COX-2), LIF, interleukin (IL)-6, IL-8, and IL-11, that allow for attachment to the uterus.40,41 LIF, along with progesterone, leads to the upregulation of IRG-1.19 Antisense ODN leads to the suppression of IRG-1 expression, resulting in impairment of embryo implantation.42 Members of IL-1 family of cytokines are important in adhesion of blastocyst. IL-1β stimulates IL-8 production that is necessary for implantation.43 IL-1α and IL-1β secreted by the embryo mediate pathways involving integrins. Both of these growth factors appear to target endometrial epithelial β3 integrin, preparing the blastocyst for adhesion.44 IL-1α upregulates integrin expression and induces changes that result in a more invasive phenotype.45 Both IL-1α and IL-1β have been detected in the sera of women undergoing IVF having higher implantation rates, suggesting that they may have an important role.46 IL-1 receptor antagonist (IL-1Ra) inhibits the actions of IL-1α and IL-1β by down-regulating integrins.47

CX3CL-1 regulates the expression of adhesion molecules, such as secreted phosphoprotein 1 (SPP1) and matrix metalloproteinases (MMPs), that mediate attachment of the implanting blastocyst.48 SPP1 co-localizes with leukocytes and macrophages and may allow for attachment to the luminal epithelium through SPP1-positive macrophages.49 In the ovine model, SPP1 was demonstrated to bind integrins (αvβ3 and α5β1) on the conceptus and luminal epithelium.50 Along with integrins, trophinin is involved in blastocyst binding to the uterine epithelium.51 Acrogranin and DKK-1 are both essential adhesion factors. The inhibition or removal of these factors reduces adhesion.30,33 Other factors involved in attachment are mucin-1 (MUC-1),52,53 heparan sulfate proteoglycans (HSPGs),54,55 and pre-implantation factor (PIF). PIF is an embryo-derived peptide playing an essential role in adhesion.56,57

As the blastocyst attaches, various molecules participate in the timing and spacing of the embryo, at least in the murine model. Lysophosphatidic acid 3 (LPA3) and cytosolic phospholipase A2α (cPLA2α) regulate embryo spacing. Mice deficient in either of these molecules have delayed implantation and abnormal spacing of embryos, resulting in smaller litter size, and, in some cases, pregnancy failure.58–60 HB-EGF-deficient mice also display delayed implantation.61

Invasion of the blastocyst upon adhesion to the uterus involves various factors. Adrenomedullin enhances invasion of trophoblasts in vitro.62 Mice with reduced expression of adrenomedullin also demonstrate reduced fertility and defect in invasion.63,64 Other factors mediating invasiveness are HGF, leptin and IGFBP-1. Both HGF and leptin induce cytotrophoblast modifications that regulate invasiveness.26,45,65 IGFBP-1 acts to inhibit IGF-I activity, preventing invasion.66

Factors involving in uterine receptivity and decidualization

Maintenance of corpus luteum (CL) is important for establishing and maintaining pregnancy. Factors such as vascular endothelial growth factor (VEGF)67 and hCG1 both participate in CL maintenance. CL secretes several hormones that allow for the establishment of pregnancy. Most importantly, it secretes progesterone that allows for the decidualization of the endometrium. Activin A is also secreted by the CL, promoting decidualization by preventing T-cell activation,68 upregulating MMPs,69 and secreting IL-11.70 IL-11 signaling through binding to its receptor is required for the development of decidua.71,72 IL-11 receptor null mice have defective decidualization and, as a result, are infertile.73 IL-6 also promotes implantation and decidualization by stimulating leptin secretion and MMP activity.74 IL-6-deficient mice show a decrease in viable implantation sites resulting in reduced fertility.75 Another important regulator of decidualization is prolactin (PRL). Mice lacking the PRL receptor exhibit implantation failures.76 hCG is responsible for the expression or upregulation of many factors that participate in the implantation process. Not only does hCG induce expression of two important implantation factors, LIF and IL-6,77 it also induces expression of COX-2.78 The COX-2 biosynthesizes prostaglandins, like prostaglandin E2 (PGE2), which affect uterine receptivity. Inhibition of COX-2 results in the inhibition of stromal cell expression, leading to decidualization failure.79,80 Homebox (HOX) A proteins, HOXA10 and HOXA11, are involved in stromal cell differentiation required for decidualization.81–83 Mice expressing HOXA10 mutants show stromal cell and decidualization defects that result in implantation failure.82,84 A few integrins, α4β1 and αvβ3, have also been implicated in having a role in decidualization.55 Other factors that present possible roles in regulation of decidualization include MIC-185 and connective tissue growth factor (CTGF).86–88

Leukocytes are recruited to help prepare the uterus for implantation. Many cytokines and chemokines are involved in the initiation of this essential inflammatory response. Colony-stimulating factor (CSF)-1, CSF-2, and CSF-3 all serve as chemoattractants in the recruitment of macrophages to the uterus.89,90 Homozygous crosses of mice lacking CSF-1 result in infertility.91 Upregulation of IL-8, CCL-2, and RANTES by progesterone has been demonstrated in vitro.92 CCL2 recruits macrophages, monocytes, natural killer (NK) cells, and T cells in the endometrium.89,93–95 CCL3, CCL4, CCL5 (RANTES), and CCL7 are also involved in the recruitment of macrophages and natural killer (NK) cells.85,89,94,96 IL-8 upregulates several inflammatory response genes.97,98 Stimulation of stromal cells in vitro with IL-23 shows an increase in IL-8 expression.99 Another chemokine responsible for upregulating the inflammatory response is CXCL1.94,100 Recent research suggests that this inflammatory environment is mediated by the trophoblast through toll-like receptors (TLRs).101 Other factors involved in the inflammatory response are PGE21 and l-selectin.102,103

Immunomodulatory regulators

Possibly the most critical aspect of successful pregnancy is maternal tolerance of the implanting embryo. Several cytokines act to suppress an immune response to the blastocyst. The IL-12/IL-18 system is important in managing immune responses. Alterations to the IL-12 or IL-18 levels have been associated with recurrent implantation failure.104 IL-18 has the ability to increase perforin expression and cytolytic potentials of uterine NK (uNK) cells,105 and its absence or overexpression can lead to implantation failure.106 IL-15, on the other hand, is thought to regulate uNK cells.85 Essential interleukins mediating maternal tolerance are IL-10 and IL-27. Mice lacking IL-10 exhibit fetal resorption because of an increased activation of cytotoxic uNK cells.107 Neutralization of IL-27 in mice also results in increased fetal resorption.108 Glycodelin is a pregnancy-specific protein shown to increase IL-10 production and reduce the expression of costimulatory molecules in monocyte-derived dendritic cells, suggesting a role in preventing an immune response.109,110 TNF-α is known to cause spontaneous abortion in mice and women.5,6,111,112 Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is thought to protect against the deleterious effect of TNF-α, by controlling uNK cell cytotoxicity and regulating of IL-15 and IL-18.108,113 TNF-α and interferon-γ (IFN-γ) cause spontaneous abortion by binding to their receptors, which are expressed in the presence of lipopolysaccharide (LPS). An in vivo model of spontaneous abortion has been created in mice by injecting mated mice with LPS. Addition of TGF-β3 to this model increased the success of pregnancy by promoting a regulatory T-cell response.111 Studies have implicated corticotrophin-releasing hormone (CRH) in the regulation of the immune response through killing of activated T cells. Administration of CRH antibodies on day 3–8 of pregnancy results in implantation failure in 60% of cases.114 A CRH receptor antagonist, antalarmin, also decreases implantation and live embryos as well as FasL expression, suggesting its role in T-cell regulation.115 Other notable factors involved in immune tolerance are hCG,116 PIF,57 interferon-stimulated 17 kDa protein (ISG-15),117 and α-fetoprotein.118

Immunocontraceptive targets

The purpose of this article is to review the factors that are involved in the establishment of pregnancy and delineate which of these factors are essential and pregnancy-specific. By selecting the proteins that are essential and pregnancy-specific, it is ensured that targeting these molecules will reduce fertility without affecting any other molecule and process. Research in this area has been rapidly progressing over the past decade. The pregnancy-specific protein, hCG, was initially used for detection of pregnancy in women. Now, it is being investigated as a contraceptive target for development of a birth control vaccine. Several vaccines based on the β subunit of hCG incorporating various carriers and adjuvants have undergone phase I and phase II clinical trials in women. A study completed in 1994 by Talwar et al. recorded that women administered an hCG vaccine developed antibody titers that prevented pregnancy. Only 1 pregnancy occurred in over 1224 cycles observed in these vaccinated women.2 Another trial demonstrated that an HSD-hCG vaccine was reversible and that titers below the protective threshold showed no teratogenic effect on pregnancy outcome.3

A more recent protein of interest is LIF. Studies performed in the mouse model have shown that hindering the interaction of LIF with its receptor will block implantation. Stewart et al. mutated the LIF gene to express a truncated, non-functional LIF mutant. The mutated DNA was injected into blastocysts and crossed the resulting F1 offsprings to create homozygous LIF-mutant mice. These mice demonstrated complete implantation failure.22 Administration of a LIF antagonist conjugated to polyethylene glycol (PEG-LA) increased blocking implantation in mice.23 More importantly, LIF is required for implantation not only in mice, but also in humans. LIF mRNA concentration peaks in human endometrium at the time of implantation.119 Studies on endometrial explants from fertile and infertile women reveal that LIF production in cultures from infertile women and fertile women, using IUD, was significantly less than that of cultures from normally cycling fertile women.120 A similar study showed immunostaining of LIF in biopsies from fertile women was higher than that of infertile women.121 Recently, it was discovered that LIF gene mutations in infertile women may account for poor IVF outcome, because maternal LIF expression is critical for implantation and successful pregnancy.122 Our laboratory recently conducted a study using a vaccine targeting LIF and its receptors in the mouse model. Preliminary results are very exciting. The administration of the vaccine to female mice developed specific antibodies resulting in a reduction in fertility in the vaccinated female mice (A.R. Lemons and R.K. Naz, unpublished data).

Other interesting molecules include glycodelin,102 oviduct-specific glycoprotein 1 (OVGP-1),103,123 trophinin, and PIF. Glycodelin A has been shown to have immunosuppressive effects against the maternal response to spermatozoa.109,110,124 Trophinin promotes activation of blastocyst for adhesion to uterine epithelium.51 Trophinin is expressed by both trophoblast and endometrial epithelial cells, and its expression seems to be regulated by hCG secretion.125 PIF is an embryo-derived peptide detected in the serum just before implantation.1 It has recently been shown to be essential for implantation by promoting adhesion, regulating immunity, and apoptosis.56,57

Conclusions

The database review identified 76 various factors that are involved in several steps of establishment of pregnancy. At least three of these factors (hCG/LIF/PIF) were found to be essential and pregnancy-specific. These molecules, besides others, may provide viable target for immunocontraception. The CV targeting factors involved in pregnancy establishment have two potential concerns: (i) Although these factors are involved in the early events of embryonic development and pre-implantation, the vaccines against them are not contraceptives in true sense because they target the post-fertilization stages, and (ii) They are ‘self’ molecules and it may be a challenging proposition to induce enough antibodies to neutralize these factors. However, the findings of phase I and phase II clinical trials of hCG vaccine in women indicate that by using appropriate carriers and adjuvants, one can modulate the ‘self’ molecule to break its tolerance and raise an immune response against these molecules in humans. Also, the hCG vaccine trials indicate that there is no teratogenic effect of the low titer residual antibodies left after the protective levels decline. The hCG vaccine trials in women have established the basis for developing a birth control vaccine, targeting various factors involved in establishment of pregnancy. A multiepitope vaccine combining factors/antigens involved in various steps of fertilization cascade and pregnancy establishment may provide a highly immunogenic and efficacious modality for contraception in humans.

Corresponding Authorinline image

Dr Rajesh K. Naz Reproductive Immunology and Molecular Biology Laboratories, Department of Obstetrics and Gynecology, West Virginia University, School of Medicine, Morgantown, WV, USA.

Acknowledgements

  1. Top of page
  2. Abstract
  3. Introduction
  4. Discussion
  5. Acknowledgements
  6. References

This work was supported in part by the NIH Grant HD24425 to RKN. We thank Briana Shiley and Meghan Hatfield for excellent typing and editorial assistance.

References

  1. Top of page
  2. Abstract
  3. Introduction
  4. Discussion
  5. Acknowledgements
  6. References
  • 1
    Duc-Goiran P, Mignot TM, Bourgeois C, Ferre F: Embryo-maternal interactions at the implantation site: a delicate equilibrium. Eur J Obstet Gynecol Reprod Biol 1999; 83:85100.
  • 2
    Talwar GP, Singh O, Pal R, Chatterjee N, Sahai P, Dhall K, Kaur J, Das SK, Suri S, Buckshee K: A vaccine that prevents pregnancy in women. Proc Natl Acad Sci USA 1994; 91:85328536.
  • 3
    Singh M, Das SK, Suri S, Singh O, Talwar GP: Regain of fertility and normality of progeny born during below protective threshold antibody titers in women immunized with the HSD-hCG vaccine. Am J Reprod Immunol 1998; 39:395398.
  • 4
    Ben-Yair E, Less A, Lev S, Ben-Yehoshua L, Tartakovsky B: Tumour necrosis factor alpha binding to human and mouse trophoblast. Cytokine 1997; 9:830836.
  • 5
    Winger EE, Reed JL: Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 2008; 60:816.
  • 6
    Clark DA: Should anti-TNF-alpha therapy be offered to patients with infertility and recurrent spontaneous abortion? Am J Reprod Immunol 2009; 61:107112.
  • 7
    Rao LV, Wikarczuk ML, Heyner S: Functional roles of insulin and insulin-like growth factors in preimplantation mouse embryo development. In Vitro Cell Dev Biol 1990; 26:10431048.
  • 8
    Koizumi N, Fukuta K: Effect of insulin on in vitro development of tetraploid mouse embryos. Exp Anim 1996; 45:179181.
  • 9
    Wang TH, Chang CL, Wu HM, Chiu YM, Chen CK, Wang HS: Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development. Fertil Steril 2006; 86:13921401.
  • 10
    O’Neill C: Autocrine mediators are required to act on the embryo by the 2-cell stage to promote normal development and survival of mouse preimplantation embryos in vitro. Biol Reprod 1998; 58:13031309.
  • 11
    Kaye PL, Harvey MB: The role of growth factors in preimplantation development. Prog Growth Factor Res 1995; 6:124.
  • 12
    Graham CH, Lysiak JJ, McCrae KR, Lala PK: Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod 1992; 46:561572.
  • 13
    Ingman WV, Robker RL, Woittiez K, Robertson SA: Null mutation in transforming growth factor beta1 disrupts ovarian function and causes oocyte incompetence and early embryo arrest. Endocrinology 2006; 147:835845.
  • 14
    Robertson SA, Sjoblom C, Jasper MJ, Norman RJ, Seamark RF: Granulocyte-macrophage colony-stimulating factor promotes glucose transport and blastomere viability in murine preimplantation embryos. Biol Reprod 2001; 64:12061215.
  • 15
    Sjoblom C, Wikland M, Robertson SA: Granulocyte-macrophage colony-stimulating factor (GM-CSF) acts independently of the beta common subunit of the GM-CSF receptor to prevent inner cell mass apoptosis in human embryos. Biol Reprod 2002; 67:18171823.
  • 16
    Rappolee DA, Sturm KS, Behrendtsen O, Schultz GA, Pedersen RA, Werb Z: Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes Dev 1992; 6:939952.
  • 17
    Rajesh H, Yong YY, Zhu M, Chia D, Yu SL: Growth hormone deficiency and supplementation at in-vitro fertilisation. Singapore Med J 2007; 48:514518.
  • 18
    Song H, Lim H, Das SK, Paria BC, Dey SK: Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice. Mol Endocrinol 2000; 14:11471161.
  • 19
    Sherwin JR, Freeman TC, Stephens RJ, Kimber S, Smith AG, Chambers I, Smith SK, Sharkey AM: Identification of genes regulated by leukemia-inhibitory factor in the mouse uterus at the time of implantation. Mol Endocrinol 2004; 18:21852195.
  • 20
    Mohamet L, Heath JK, Kimber SJ: Determining the LIF-sensitive period for implantation using a LIF-receptor antagonist. Reproduction 2009; 138:827836.
  • 21
    Rodriguez CI, Cheng JG, Liu L, Stewart CL: Cochlin, a secreted von Willebrand factor type a domain-containing factor, is regulated by leukemia inhibitory factor in the uterus at the time of embryo implantation. Endocrinology 2004; 145:14101418.
  • 22
    Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ: Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359:7679.
  • 23
    White CA, Zhang JG, Salamonsen LA, Baca M, Fairlie WD, Metcalf D, Nicola NA, Robb L, Dimitriadis E: Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy. Proc Natl Acad Sci USA 2007; 104:1935719362.
  • 24
    Jessmon P, Leach RE, Armant DR: Diverse functions of HBEGF during pregnancy. Mol Reprod Dev 2009; 76:11161127.
  • 25
    Burdsal CA, Flannery ML, Pedersen RA: FGF-2 alters the fate of mouse epiblast from ectoderm to mesoderm in vitro. Dev Biol 1998; 198:231244.
  • 26
    Hill JA: Maternal-embryonic cross-talk. Ann N Y Acad Sci 2001; 943:1725.
  • 27
    Kane MT, Morgan PM, Coonan C: Peptide growth factors and preimplantation development. Hum Reprod Update 1997; 3:137157.
  • 28
    Harada T, Fujikawa T, Yoshida S, Onohara Y, Tanikawa M, Terakawa N: Expression of transforming growth factor alpha (TGF-alpha) gene in mouse embryonic development. J Assist Reprod Genet 1997; 14:262269.
  • 29
    Diaz-Cueto L, Stein P, Jacobs A, Schultz RM, Gerton GL: Modulation of mouse preimplantation embryo development by acrogranin (epithelin/granulin precursor). Dev Biol 2000; 217:406418.
  • 30
    Qin J, Diaz-Cueto L, Schwarze JE, Takahashi Y, Imai M, Isuzugawa K, Yamamoto S, Chang KT, Gerton GL, Imakawa K: Effects of progranulin on blastocyst hatching and subsequent adhesion and outgrowth in the mouse. Biol Reprod 2005; 73:434442.
  • 31
    Smith RM, Garside WT, Aghayan M, Shi CZ, Shah N, Jarett L, Heyner S: Mouse preimplantation embryos exhibit receptor-mediated binding and transcytosis of maternal insulin-like growth factor I. Biol Reprod 1993; 49:112.
  • 32
    Kawamura K, Sato N, Fukuda J, Kodama H, Kumagai J, Tanikawa H, Murata M, Tanaka T: The role of leptin during the development of mouse preimplantation embryos. Mol Cell Endocrinol 2003; 202:185189.
  • 33
    Li J, Liu WM, Cao YJ, Peng S, Zhang Y, Duan EK: Roles of Dickkopf-1 and its receptor Kremen1 during embryonic implantation in mice. Fertil Steril 2008; 90:14701479.
  • 34
    Hannan NJ, Jones RL, White CA, Salamonsen LA: The chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at the feto-maternal interface. Biol Reprod 2006; 74:896904.
  • 35
    Wright JK, Dunk CE, Perkins JE, Winterhager E, Kingdom JC, Lye SJ: EGF modulates trophoblast migration through regulation of Connexin 40. Placenta 2006; 27(Suppl A):S114S121.
  • 36
    Qiu Q, Yangi MY, Tsang BK, Gruslin A: Both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signalling are required in epidermal growth factor-induced human trophoblast migration. Mol Hum Reprod 2004; 10:677684.
  • 37
    Kabir-Salmani M, Shiokawa S, Akimoto Y, Sakai K, Iwashita M: The role of alpha(5)beta(1)-integrin in the IGF-I-induced migration of extravillous trophoblast cells during the process of implantation. Mol Hum Reprod 2004; 10:9197.
  • 38
    Kabir-Salmani M, Shiokawa S, Akimoto Y, Sakai K, Nagamatsu S, Nakamura Y, Lotfi A, Kawakami H, Iwashita M: Alphavbeta3 integrin signaling pathway is involved in insulin-like growth factor I-stimulated human extravillous trophoblast cell migration. Endocrinology 2003; 144:16201630.
  • 39
    Jones RL, Stoikos C, Findlay JK, Salamonsen LA: TGF-beta superfamily expression and actions in the endometrium and placenta. Reproduction 2006; 132:217232.
  • 40
    Evans J, Catalano RD, Morgan K, Critchley HO, Millar RP, Jabbour HN: Prokineticin 1 signaling and gene regulation in early human pregnancy. Endocrinology 2008; 149:28772887.
  • 41
    Evans J, Catalano RD, Brown P, Sherwin R, Critchley HO, Fazleabas AT, Jabbour HN: Prokineticin 1 mediates fetal-maternal dialogue regulating endometrial leukemia inhibitory factor. FASEB J 2009; 23:21652175.
  • 42
    Cheon YP, Xu X, Bagchi MK, Bagchi IC: Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse. Endocrinology 2003; 144:56235630.
  • 43
    Hirota Y, Osuga Y, Hasegawa A, Kodama A, Tajima T, Hamasaki K, Koga K, Yoshino O, Hirata T, Harada M, Takemura Y, Yano T, Tsutsumi O, Taketani Y: Interleukin (IL)-1beta stimulates migration and survival of first-trimester villous cytotrophoblast cells through endometrial epithelial cell-derived IL-8. Endocrinology 2009; 150:350356.
  • 44
    Simon C, Moreno C, Remohi J, Pellicer A: Molecular interactions between embryo and uterus in the adhesion phase of human implantation. Hum Reprod 1998; 13(Suppl 3):219232.
  • 45
    Gonzalez RR, Devoto L, Campana A, Bischof P: Effects of leptin, interleukin-1alpha, interleukin-6, and transforming growth factor-beta on markers of trophoblast invasive phenotype: integrins and metalloproteinases. Endocrine 2001; 15:157164.
  • 46
    Karagouni EE, Chryssikopoulos A, Mantzavinos T, Kanakas N, Dotsika EN: Interleukin-1beta and interleukin-1alpha may affect the implantation rate of patients undergoing in vitro fertilization-embryo transfer. Fertil Steril 1998; 70:553559.
  • 47
    Simon C, Valbuena D, Krussel J, Bernal A, Murphy CR, Shaw T, Pellicer A, Polan ML: Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium. Fertil Steril 1998; 70:896906.
  • 48
    Hannan NJ, Salamonsen LA: CX3CL1 and CCL14 regulate extracellular matrix and adhesion molecules in the trophoblast: potential roles in human embryo implantation. Biol Reprod 2008; 79:5865.
  • 49
    White FJ, Burghardt RC, Hu J, Joyce MM, Spencer TE, Johnson GA: Secreted phosphoprotein 1 (osteopontin) is expressed by stromal macrophages in cyclic and pregnant endometrium of mice, but is induced by estrogen in luminal epithelium during conceptus attachment for implantation. Reproduction 2006; 132:919929.
  • 50
    Kim J, Erikson DW, Burghardt RC, Spencer TE, Wu G, Bayless KJ, Johnson GA, Bazer FW: Secreted phosphoprotein 1 binds integrins to initiate multiple cell signaling pathways, including FRAP1/mTOR, to support attachment and force-generated migration of trophectoderm cells. Matrix Biol 2010; 29:369382.
  • 51
    Sugihara K, Sugiyama D, Byrne J, Wolf DP, Lowitz KP, Kobayashi Y, Kabir-Salmani M, Nadano D, Aoki D, Nozawa S, Nakayama J, Mustelin T, Ruoslahti E, Yamaguchi N, Fukuda MN: Trophoblast cell activation by trophinin ligation is implicated in human embryo implantation. Proc Natl Acad Sci USA 2007; 104:37993804.
  • 52
    Braga VM, Gendler SJ: Modulation of Muc-1 mucin expression in the mouse uterus during the estrus cycle, early pregnancy and placentation. J Cell Sci 1993; 105:397405.
  • 53
    Dharmaraj N, Gendler SJ, Carson DD: Expression of human MUC1 during early pregnancy in the human MUC1 transgenic mouse model. Biol Reprod 2009; 81:11821188.
  • 54
    Carson DD, Tang JP, Julian J: Heparan sulfate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence. Dev Biol 1993; 155:97106.
  • 55
    Yoshinaga K: Research on Blastocyst Implantation Essential Factors (BIEFs). Am J Reprod Immunol 2010; 63:413424.
  • 56
    Duzyj CM, Barnea ER, Li M, Huang SJ, Krikun G, Paidas MJ: Preimplantation factor promotes first trimester trophoblast invasion. Am J Obstet Gynecol 2010; 203:e401e404.
  • 57
    Paidas MJ, Krikun G, Huang SJ, Jones R, Romano M, Annunziato J, Barnea ER: A genomic and proteomic investigation of the impact of preimplantation factor on human decidual cells. Am J Obstet Gynecol 2010; 202:e451e458.
  • 58
    Ye X, Hama K, Contos JJ, Anliker B, Inoue A, Skinner MK, Suzuki H, Amano T, Kennedy G, Arai H, Aoki J, Chun J: LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 2005; 435:104108.
  • 59
    Hama K, Aoki J, Inoue A, Endo T, Amano T, Motoki R, Kanai M, Ye X, Chun J, Matsuki N, Suzuki H, Shibasaki M, Arai H: Embryo spacing and implantation timing are differentially regulated by LPA3-mediated lysophosphatidic acid signaling in mice. Biol Reprod 2007; 77:954959.
  • 60
    Song H, Lim H, Paria BC, Matsumoto H, Swift LL, Morrow J, Bonventre JV, Dey SK: Cytosolic phospholipase A2alpha is crucial [correction of A2alpha deficiency is crucial] for ‘on-time’ embryo implantation that directs subsequent development. Development 2002; 129:28792889.
  • 61
    Xie H, Wang H, Tranguch S, Iwamoto R, Mekada E, Demayo FJ, Lydon JP, Das SK, Dey SK: Maternal heparin-binding-EGF deficiency limits pregnancy success in mice. Proc Natl Acad Sci USA 2007; 104:1831518320.
  • 62
    Zhang X, Green KE, Yallampalli C, Dong YL: Adrenomedullin enhances invasion by trophoblast cell lines. Biol Reprod 2005; 73:619626.
  • 63
    Li M, Yee D, Magnuson TR, Smithies O, Caron KM: Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice. J Clin Invest 2006; 116:26532662.
  • 64
    Li M, Wu Y, Caron KM: Haploinsufficiency for adrenomedullin reduces pinopodes and diminishes uterine receptivity in mice. Biol Reprod 2008; 79:11691175.
  • 65
    Gonzalez RR, Caballero-Campo P, Jasper M, Mercader A, Devoto L, Pellicer A, Simon C: Leptin and leptin receptor are expressed in the human endometrium and endometrial leptin secretion is regulated by the human blastocyst. J Clin Endocrinol Metab 2000; 85:48834888.
  • 66
    Nardo LG, Nikas G, Makrigiannakis A: Molecules in blastocyst implantation. Role of matrix metalloproteinases, cytokines and growth factors. J Reprod Med 2003; 48:137147.
  • 67
    Sugino N, Kashida S, Takiguchi S, Karube A, Kato H: Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy. J Clin Endocrinol Metab 2000; 85:39193924.
  • 68
    Segerer SE, Muller N, Brandt J, Kapp M, Dietl J, Reichardt HM, Rieger L, Kammerer U: The glycoprotein-hormones activin A and inhibin A interfere with dendritic cell maturation. Reprod Biol Endocrinol 2008; 6:17.
  • 69
    Jones RL, Findlay JK, Farnworth PG, Robertson DM, Wallace E, Salamonsen LA: Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion. Endocrinology 2006; 147:724732.
  • 70
    Menkhorst E, Salamonsen LA, Zhang J, Harrison CA, Gu J, Dimitriadis E: Interleukin 11 and activin A synergise to regulate progesterone-induced but not cAMP-induced decidualization. J Reprod Immunol 2010; 84:124132.
  • 71
    Bilinski P, Roopenian D, Gossler A: Maternal IL-11Ralpha function is required for normal decidua and fetoplacental development in mice. Genes Dev 1998; 12:22342243.
  • 72
    Karpovich N, Klemmt P, Hwang JH, McVeigh JE, Heath JK, Barlow DH, Mardon HJ: The production of interleukin-11 and decidualization are compromised in endometrial stromal cells derived from patients with infertility. J Clin Endocrinol Metab 2005; 90:16071612.
  • 73
    Robb L, Li R, Hartley L, Nandurkar HH, Koentgen F, Begley CG: Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat Med 1998; 4:303308.
  • 74
    Meisser A, Cameo P, Islami D, Campana A, Bischof P: Effects of interleukin-6 (IL-6) on cytotrophoblastic cells. Mol Hum Reprod 1999; 5:10551058.
  • 75
    Dimitriadis E, White CA, Jones RL, Salamonsen LA: Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update 2005; 11:613630.
  • 76
    Reese J, Binart N, Brown N, Ma WG, Paria BC, Das SK, Kelly PA, Dey SK: Implantation and decidualization defects in prolactin receptor (PRLR)-deficient mice are mediated by ovarian but not uterine PRLR. Endocrinology 2000; 141:18721881.
  • 77
    Perrier d’HauteriveS, Charlet-Renard C, Berndt S, Dubois M, Munaut C, Goffin F, Hagelstein MT, Noel A, Hazout A, Foidart JM, Geenen V: Human chorionic gonadotropin and growth factors at the embryonic-endometrial interface control leukemia inhibitory factor (LIF) and interleukin 6 (IL-6) secretion by human endometrial epithelium. Hum Reprod 2004; 19:26332643.
  • 78
    Sales KJ, Grant V, Catalano RD, Jabbour HN: Chorionic gonadotropin regulates CXCR4 Expression In Human Endometrium Via E-Series Prostanoid Receptor 2 signalling to PI3K-ERK1/2: implications for fetal-maternal cross-talk for embryo implantation. Mol Hum Reprod 2011; 17:2232.
  • 79
    Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, Dey SK: Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997; 91:197208.
  • 80
    Scherle PA, Ma W, Lim H, Dey SK, Trzaskos JM: Regulation of cyclooxygenase-2 induction in the mouse uterus during decidualization. An event of early pregnancy. J Biol Chem 2000; 275:3708637092.
  • 81
    Gendron RL, Paradis H, Hsieh-Li HM, Lee DW, Potter SS, Markoff E: Abnormal uterine stromal and glandular function associated with maternal reproductive defects in Hoxa-11 null mice. Biol Reprod 1997; 56:10971105.
  • 82
    Lim H, Ma L, Ma WG, Maas RL, Dey SK: Hoxa-10 regulates uterine stromal cell responsiveness to progesterone during implantation and decidualization in the mouse. Mol Endocrinol 1999; 13:10051017.
  • 83
    Godbole G, Modi D: Regulation of decidualization, interleukin-11 and interleukin-15 by homeobox A 10 in endometrial stromal cells. J Reprod Immunol 2010; 85:130139.
  • 84
    Benson GV, Lim H, Paria BC, Satokata I, Dey SK, Maas RL: Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development 1996; 122:26872696.
  • 85
    Salamonsen LA, Hannan NJ, Dimitriadis E: Cytokines and chemokines during human embryo implantation: roles in implantation and early placentation. Semin Reprod Med 2007; 25:437444.
  • 86
    Surveyor GA, Wilson AK, Brigstock DR: Localization of connective tissue growth factor during the period of embryo implantation in the mouse. Biol Reprod 1998; 59:12071213.
  • 87
    Uzumcu M, Homsi MF, Ball DK, Coskun S, Jaroudi K, Hollanders JM, Brigstock DR: Localization of connective tissue growth factor in human uterine tissues. Mol Hum Reprod 2000; 6:10931098.
  • 88
    Rageh MA, Moussad EE, Wilson AK, Brigstock DR: Steroidal regulation of connective tissue growth factor (CCN2; CTGF) synthesis in the mouse uterus. Mol Pathol 2001; 54:338346.
  • 89
    Wood GW, Hausmann E, Choudhuri R: Relative role of CSF-1, MCP-1/JE, and RANTES in macrophage recruitment during successful pregnancy. Mol Reprod Dev 1997; 46:6269.
  • 90
    Litwin S, Lagadari M, Barrientos G, Roux ME, Margni R, Miranda S: Comparative immunohistochemical study of M-CSF and G-CSF in feto-maternal interface in a multiparity mouse model. Am J Reprod Immunol 2005; 54:311320.
  • 91
    Pollard JW, Hunt JS, Wiktor-Jedrzejczak W, Stanley ER: A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Dev Biol 1991; 148:273283.
  • 92
    Caballero-Campo P, Dominguez F, Coloma J, Meseguer M, Remohi J, Pellicer A, Simon C: Hormonal and embryonic regulation of chemokines IL-8, MCP-1 and RANTES in the human endometrium during the window of implantation. Mol Hum Reprod 2002; 8:375384.
  • 93
    Garcia-Velasco JA, Arici A: Chemokines and human reproduction. Fertil Steril 1999; 71:983993.
  • 94
    Wood GW, Hausmann EH, Kanakaraj K: Expression and regulation of chemokine genes in the mouse uterus during pregnancy. Cytokine 1999; 11:10381045.
  • 95
    Meter RA, Wira CR, Fahey JV: Secretion of monocyte chemotactic protein-1 by human uterine epithelium directs monocyte migration in culture. Fertil Steril 2005; 84:191201.
  • 96
    Nautiyal J, Kumar PG, Laloraya M: Mifepristone (Ru486) antagonizes monocyte chemotactic protein-3 down-regulation at early mouse pregnancy revealing immunomodulatory events in Ru486 induced abortion. Am J Reprod Immunol 2004; 52:818.
  • 97
    Popovici RM, Betzler NK, Krause MS, Luo M, Jauckus J, Germeyer A, Bloethner S, Schlotterer A, Kumar R, Strowitzki T, von WolffM: Gene expression profiling of human endometrial-trophoblast interaction in a coculture model. Endocrinology 2006; 147:56625675.
  • 98
    Jones RL, Hannan NJ, Kaitu’u TJ, Zhang J, Salamonsen LA: Identification of chemokines important for leukocyte recruitment to the human endometrium at the times of embryo implantation and menstruation. J Clin Endocrinol Metab 2004; 89:61556167.
  • 99
    Uz YH, Murk W, Yetkin CE, Kayisli UA, Arici A: Expression and role of interleukin-23 in human endometrium throughout the menstrual cycle and early pregnancy. J Reprod Immunol 2010; 87:2127.
  • 100
    Hess AP, Hamilton AE, Talbi S, Dosiou C, Nyegaard M, Nayak N, Genbecev-Krtolica O, Mavrogianis P, Ferrer K, Kruessel J, Fazleabas AT, Fisher SJ, Giudice LC: Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators. Biol Reprod 2007; 76:102117.
  • 101
    Koga K, Aldo PB, Mor G: Toll-like receptors and pregnancy: trophoblast as modulators of the immune response. J Obstet Gynecol Res 2009; 35:191202.
  • 102
    Xie X, Kang Z, Anderson LN, He H, Lu B, Anne CroyB: Analysis of the contributions of L-selectin and CXCR3 in mediating leukocyte homing to pregnant mouse uterus. Am J Reprod Immunol 2005; 53:112.
  • 103
    Wang B, Sheng JZ, He RH, Qian YL, Jin F, Huang HF: High expression of L-selectin ligand in secretory endometrium is associated with better endometrial receptivity and facilitates embryo implantation in human being. Am J Reprod Immunol 2008; 60:127134.
  • 104
    Ledee-Bataille N, Dubanchet S, Coulomb-L’hermine A, Durand-Gasselin I, Frydman R, Chaouat G: A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure after in vitro fertilization. Fertil Steril 2004; 81:5965.
  • 105
    Tokmadzic VS, Tsuji Y, Bogovic T, Laskarin G, Cupurdija K, Strbo N, Koyama K, Okamura H, Podack ER, Rukavina D: IL-18 is present at the maternal-fetal interface and enhances cytotoxic activity of decidual lymphocytes. Am J Reprod Immunol 2002; 48:191200.
  • 106
    Kralickova M, Sima P, Rokyta Z: Role of the leukemia-inhibitory factor gene mutations in infertile women: the embryo-endometrial cytokine cross talk during implantation – a delicate homeostatic equilibrium. Folia Microbiol (Praha) 2005; 50:179186.
  • 107
    Murphy SP, Fast LD, Hanna NN, Sharma S: Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol 2005; 175:40844090.
  • 108
    Mas AE, Petitbarat M, Dubanchet S, Fay S, Ledee N, Chaouat G: Immune regulation at the interface during early steps of murine implantation: involvement of two new cytokines of the IL-12 family (IL-23 and IL-27) and of TWEAK. Am J Reprod Immunol 2008; 59:323338.
  • 109
    Vigne JL, Hornung D, Mueller MD, Taylor RN: Purification and characterization of an immunomodulatory endometrial protein, glycodelin. J Biol Chem 2001; 276:1710117105.
  • 110
    Scholz C, Toth B, Brunnhuber R, Rampf E, Weissenbacher T, Santoso L, Friese K, Jeschke U: Glycodelin A induces a tolerogenic phenotype in monocyte-derived dendritic cells in vitro. Am J Reprod Immunol 2008; 60:501512.
  • 111
    Clark DA, Fernandes J, Banwatt D: Prevention of spontaneous abortion in the CBA x DBA/2 mouse model by intravaginal TGF-beta and local recruitment of CD4+8+ FOXP3+ cells. Am J Reprod Immunol 2008; 59:525534.
  • 112
    Petkovic AB, Matic SM, Stamatovic NV, Vojvodic DV, Todorovic TM, Lazic ZR, Kozomara RJ: Proinflammatory cytokines (IL-1beta and TNF-alpha) and chemokines (IL-8 and MIP-1alpha) as markers of peri-implant tissue condition. Int J Oral Maxillofac Surg 2010; 39:478485.
  • 113
    Petitbarat M, Serazin V, Dubanchet S, Wayner R, de MazancourtP, Chaouat G, Ledee N: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor inducible-14 might regulate the effects of interleukin 18 and 15 in the human endometrium. Fertil Steril 2010; 94:11411143.
  • 114
    Athanassakis I, Farmakiotis V, Aifantis I, Gravanis A, Vassiliadis S: Expression of corticotrophin-releasing hormone in the mouse uterus: participation in embryo implantation. J Endocrinol 1999; 163:221227.
  • 115
    Makrigiannakis A, Zoumakis E, Kalantaridou S, Coutifaris C, Margioris AN, Coukos G, Rice KC, Gravanis A, Chrousos GP: Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat Immunol 2001; 2:10181024.
  • 116
    Cole LA: Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol 2010; 8:102.
  • 117
    Austin KJ, Bany BM, Belden EL, Rempel LA, Cross JC, Hansen TR: Interferon-stimulated gene-15 (Isg15) expression is up-regulated in the mouse uterus in response to the implanting conceptus. Endocrinology 2003; 144:31073113.
  • 118
    Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, Fisher SJ: Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996; 184:539548.
  • 119
    Charnock-Jones DS, Sharkey AM, Fenwick P, Smith SK: Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil 1994; 101:421426.
  • 120
    Delage G, Moreau JF, Taupin JL, Freitas S, Hambartsoumian E, Olivennes F, Fanchin R, Letur-Konirsch H, Frydman R, Chaouat G: In-vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women. Hum Reprod 1995; 10:24832488.
  • 121
    Tsai HD, Chang CC, Hsieh YY, Lo HY: Leukemia inhibitory factor expression in different endometrial locations between fertile and infertile women throughout different menstrual phases. J Assist Reprod Genet 2000; 17:415418.
  • 122
    Novotny Z, Krizan J, Sima R, Sima P, Uher P, Zech N, Hutelova R, Baborova P, Ulcova-Gallova Z, Subrt I, Ulmanova E, Houdek Z, Rokyta Z, Babuska V, Kralickova M: Leukaemia inhibitory factor (LIF) gene mutations in women diagnosed with unexplained infertility and endometriosis have a negative impact on the IVF outcome. A pilot study. Folia Biol (Praha) 2009; 55:9297.
  • 123
    O’Day-Bowman MB, Mavrogianis PA, Reuter LM, Johnson DE, Fazleabas AT, Verhage HG: Association of oviduct-specific glycoproteins with human and baboon (Papio anubis) ovarian oocytes and enhancement of human sperm binding to human hemizonae following in vitro incubation. Biol Reprod 1996; 54:6069.
  • 124
    Seppala M, Koistinen H, Koistinen R, Chiu PCN, Yeung WSB: Glycosylation related actions of glycodelin: gamete, cumulus cell, immune cell and clinical associations. Hum Reprod Update 2007; 13:275287.
  • 125
    Nakayama J, Aoki D, Suga T, Akama TO, Ishizone S, Yamaguchi H, Imakawa K, Nadano D, Fazleabas AT, Katsuyama T, Nozawa S, Fukuda MN: Implantation-dependent expression of trophinin by maternal fallopian tube epithelia during tubal pregnancies – possible role of human chorionic gonadotrophin on ectopic pregnancy. Am J Path 2003; 163:22112219.